Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Aaron Seth Kesselheim, M.D.


This page shows the publications co-authored by Aaron Kesselheim and William Feldman.
Connection Strength

  1. Switching to Over-the-Counter Availability of Rescue Inhalers for Asthma. JAMA. 2022 03 15; 327(11):1021-1022.
    View in: PubMed
    Score: 0.992
  2. Payer-Specific Negotiated Prices for Prescription Drugs at Top-Performing US Hospitals. JAMA Intern Med. 2022 01 01; 182(1):83-86.
    View in: PubMed
    Score: 0.979
  3. Trends in Medicare Part D Inhaler Spending: 2012-2018. Ann Am Thorac Soc. 2021 03; 18(3):548-550.
    View in: PubMed
    Score: 0.923
  4. The Future of Drug-Pricing Transparency. N Engl J Med. 2021 02 11; 384(6):489-491.
    View in: PubMed
    Score: 0.915
  5. Potential Medicare Savings on Inhaler Prescriptions Through the Use of Negotiated Prices and a Defined Formulary. JAMA Intern Med. 2020 03 01; 180(3):454-456.
    View in: PubMed
    Score: 0.862
  6. Public Approval of Exception From Informed Consent in Emergency Clinical Trials: A Systematic Review of Community Consultation Surveys. JAMA Netw Open. 2019 07 03; 2(7):e197591.
    View in: PubMed
    Score: 0.823
  7. A Systematic Review Of The Food And Drug Administration's 'Exception From Informed Consent' Pathway. Health Aff (Millwood). 2018 10; 37(10):1605-1614.
    View in: PubMed
    Score: 0.781
  8. Biosimilar competition: Early learning. Health Econ. 2022 04; 31(4):647-663.
    View in: PubMed
    Score: 0.245
  9. A Multi-modal Approach to Evaluate the Impact of Risk Evaluation and Mitigation Strategy (REMS) Programs. Drug Saf. 2021 Jul; 44(7):743-751.
    View in: PubMed
    Score: 0.233
  10. Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation. Milbank Q. 2021 03; 99(1):240-272.
    View in: PubMed
    Score: 0.231
  11. Drug Prices, Rebates, and Discounts. JAMA. 2020 07 28; 324(4):399.
    View in: PubMed
    Score: 0.222
  12. Surrogate Endpoints and Drug Regulation: What Is Needed to Clarify the Evidence. J Law Med Ethics. 2019 09; 47(3):381-387.
    View in: PubMed
    Score: 0.208
  13. Projected spending for brand-name drugs in English primary care given US prices: a cross-sectional study. J R Soc Med. 2020 09; 113(9):350-359.
    View in: PubMed
    Score: 0.056
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.